Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses

被引:18
|
作者
Waeckerle-Men, Ying [1 ]
Mauracher, Andrea [1 ]
Hakerud, Monika [2 ]
Mohanan, Deepa [1 ]
Kuendig, Thomas M. [1 ]
Hogset, Anders [2 ]
Johansen, Pal [1 ]
机构
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[2] PCI Biotech AS, Strandveien, Lysaker, Norway
关键词
Photosensitiser; Amphinex; Vaccines; Immunisation; Adjuvants; Mice; Antigen presentation; T cells; Apoptosis; VACCINE DELIVERY-SYSTEMS; DENDRITIC CELLS; DRUG-DELIVERY; CANCER-THERAPY; INTRACELLULAR DELIVERY; MONOCLONAL-ANTIBODIES; CROSS-PRESENTATION; EXOGENOUS ANTIGEN; PRESENTING CELLS; TYROSINE KINASE;
D O I
10.1016/j.ejpb.2013.02.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tumour chemotherapy with drugs is typically associated with severe systemic and local side effects for which reason immunotherapy represents a safer alternative. However, vaccination often fails to generate the required cytotoxic CD8 T-cell responses due to insufficient access of antigens to the cytosol and the MHC class I pathway of antigen presentation. One important issue of tumour research is therefore to develop strategies that allow cytosolic targeting or endosomal escape of tumour antigens. The objective of the current study was to test whether endocytosed antigen could be delivered to MHC class I by means of photochemical internalisation (PCI). Briefly, the antigen and the photosensitiser Amphinex were loaded in vitro onto bone-marrow-derived murine dendritic cells (DCs). After light activation, which is supposed to cause disruption of OVA- and Amphinex-containing endosomes, the DCs were cultured with OVA-specific CD8 T cells or used for immunisation of mice. PCI facilitated CD8 T-cell responses as measured by IFN-gamma secretion in vitro and CD8 T-cell proliferation in vivo. In conclusion, the current proof-of-concept study is the first to describe PCI-mediated immunisation and the results revealed the feasibility of this novel technology in autologous vaccination for stimulation of CD8 T-cell responses. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 50 条
  • [31] Predicting T cell recognition of MHC class I restricted neoepitopes
    Kosaloglu-Yalcin, Zeynep
    Lanka, Manasa
    Frentzen, Angela
    Premlal, Ashmitaa Logandha Ramamoorthy
    Sidney, John
    Vaughan, Kerrie
    Greenbaum, Jason
    Robbins, Paul
    Gartner, Jared
    Sette, Alessandro
    Peters, Bjoern
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [32] Exogenous antigens and the stimulation of MHC class I restricted cell-mediated cytotoxicity: possible strategies for fish vaccines
    Dijkstra, JM
    Fischer, U
    Sawamoto, Y
    Ototake, M
    Nakanishi, T
    FISH & SHELLFISH IMMUNOLOGY, 2001, 11 (06) : 437 - 458
  • [33] T-CELL STRATEGIES IN AIDS VACCINES - MHC-RESTRICTED T-CELL RESPONSES TO HIV PROTEINS
    MILLS, KHG
    NIXON, DF
    MCMICHAEL, AJ
    AIDS, 1989, 3 : S101 - S110
  • [34] Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins
    MAndelboim, O
    Davis, DM
    Reyburn, HT
    ValesGomez, M
    Sheu, EG
    Pazmany, L
    Strominger, JL
    SCIENCE, 1996, 274 (5295) : 2097 - 2100
  • [35] CD8+ T-CELL INTERACTIONS WITH TOXOPLASMA-GONDII - IMPLICATIONS FOR PROCESSING OF ANTIGEN FOR CLASS-I-RESTRICTED RECOGNITION
    DENKERS, EY
    SHER, A
    GAZZINELLI, RT
    RESEARCH IN IMMUNOLOGY, 1993, 144 (01): : 51 - 57
  • [36] THE V-BETA COMPLEMENTARITY-DETERMINING REGION-1 OF A MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I-RESTRICTED T-CELL RECEPTOR IS INVOLVED IN THE RECOGNITION OF PEPTIDE/MHC-I AND SUPERANTIGEN/MHC-II COMPLEX
    BELLIO, M
    LONE, YC
    DELACALLEMARTIN, O
    MALISSEN, B
    ABASTADO, JP
    KOURILSKY, P
    JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04): : 1087 - 1097
  • [37] DIFFERENCES IN ANTIGEN PRESENTATION TO MHC CLASS-I-RESTRICTED AND CLASS-II-RESTRICTED INFLUENZA VIRUS-SPECIFIC CYTOLYTIC LYMPHOCYTE-T CLONES
    MORRISON, LA
    LUKACHER, AE
    BRACIALE, VL
    FAN, DP
    BRACIALE, TJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (04): : 903 - 921
  • [38] CHARACTERIZATION OF MHC CLASS II-RESTRICTED T-CELL RECEPTORS FOR T-CELL THERAPY OF HBV INFECTION
    Schreiber, S.
    Honz, M.
    Schiemann, M.
    Sette, A.
    Zielinski, C.
    Protzer, U.
    Wisskirchen, K.
    HUMAN GENE THERAPY, 2019, 30 (12) : A10 - A10
  • [39] CHARACTERIZATION OF MHC CLASS II-RESTRICTED T-CELL RECEPTORS FOR T-CELL THERAPY OF HBV INFECTION
    Schreiber, S.
    Honz, M.
    Schiemann, M.
    Zielinski, C.
    Protzer, U.
    Wisskirchen, K.
    CYTOTHERAPY, 2019, 21 (05) : S10 - S10
  • [40] Characterization of MHC Class II-Restricted T-Cell Receptors for T-Cell Therapy of HBV Infection
    Schreiber, Sophia
    Honz, Melanie
    Schiemann, Matthias
    Sette, Alessandro
    Zielinski, Christina
    Protzer, Ulrike
    Wisskirchen, Karin
    MOLECULAR THERAPY, 2020, 28 (04) : 520 - 520